- In April 2023, Cutera, Inc., a leading provider of aesthetic and dermatology solutions, announced the launch of AviClear in key international markets. AviClear is the first FDA-cleared energy-based device for the treatment of mild to severe acne. The expansion reflects Cutera’s strategic push to broaden its global footprint and meet growing demand for non-invasive, energy-based dermatological treatments. This move underscores the company's dedication to offering innovative solutions in high-growth segments of aesthetic dermatology
- In March 2023, Cynosure LLC introduced the Potenza RF Microneedling system in Europe and Asia-Pacific, designed for customizable skin rejuvenation. The system leverages monopolar and bipolar RF energy with ultrafine needles for deep and surface-level treatments. This development reflects Cynosure's commitment to expanding its product portfolio with versatile, minimally invasive devices, catering to both physicians and patients seeking personalized aesthetic outcomes with minimal downtime
- In March 2023, Lumenis Be Ltd. partnered with a network of leading aesthetic clinics in South Korea to introduce its Stellar M22 multi-application platform. This advanced device combines IPL, Nd:YAG, and ResurFX technologies to offer treatments for over 30 skin conditions. The partnership underscores Lumenis’ intent to tap into the growing Asia-Pacific aesthetic market by offering clinicians a flexible, multi-functional solution that meets diverse skin needs
- In February 2023, InMode Ltd. launched its EmpowerRF platform in Canada, targeting the women’s wellness and aesthetic market. EmpowerRF combines multiple technologies—RF microneedling, fractional RF, and muscle stimulation—to treat a wide range of conditions including skin laxity, tone, and pelvic floor disorders. The launch highlights InMode’s focus on holistic, technology-driven platforms that address both functional and aesthetic concerns, expanding its footprint in North America
- In January 2023, Alma Lasers GmbH, a global provider of aesthetic and surgical lasers, unveiled the Alma Hybrid system at IMCAS World Congress 2023 in Paris. This device integrates ablative, non-ablative, and thermal technologies into one platform, allowing physicians to customize treatments for scars, wrinkles, and texture irregularities. Alma’s introduction of this hybrid solution reflects the industry's broader move toward adaptable and combination-based therapies, providing patients with more precise and comprehensive treatment options
